DIF-TES-ADT; 2,8-二氟-5,11-双(三乙基甲硅烷基乙炔基)蒽噻吩,正反异构体的混合物; ((2,8-Difluoroanthra[2,3-b:6,7-b']dithiophene-5,11-diyl)bis(ethyne-2,1-diyl))bis(triethylsilane); DIF-TES-ADT; 2,8-Difluoro-5,11-bis(triethylsilylethynyl)anthradithiophene,mixture of syn & anti isomers; Anthra[2,3-b:6,7-b']dithiophene, 2,8-difluoro-5,11-bis[2-(triethylsilyl)ethynyl]-; 2,8-difluoro-5,11-bis(triethylsilylethynyl)anthra[2,3-b:6,7-b']dithiophene
- 生物活性
PSI-7409是 Sofosbuvir (PSI-7977) 的5'-三磷酸活性代谢物。Sofosbuvir (PSI-7977) 是选择性和高活性的 HCV 核苷酸类似物抑制剂。
- 体外研究
PSI-7409 inhibits the enzymatic activities of these NS5BΔ21 polymerases in a dose-dependent manner. The IC
50
s for PSI-7409 against GT 1b, 2a, 3a, and 4a NS5B polymerases are 1.6 μM, 2.8 μM, 0.7 μM, and 2.6 μM, respectively. PSI-7409 is a weak inhibitor of DNA Pol α (IC
50
=550 μM). DNA Pol β and γ are not inhibited by 1 mM PSI-7409. A significant amount of RNA product is made in the presence of 500 μM PSI-7409, about 85%. In clone A cells, the levels of PSI-7409 gradually increases to a maximum concentration of about 25 μm over a period of 48 h. PSI-7409 forms at a much faster rate in primary human hepatocytes, achieving a maximum intracellular concentration of ∼100 μM at 4 h and remains at that concentration for 48 h.
